Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, updates readers on moves by the medical devices regulator to collaborate with Northern Ireland’s MedTech sector.
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has announced the establishment of a new regulatory hub in Belfast, marking a significant step in strengthening collaboration with Northern Ireland’s rapidly expanding life sciences sector.
Northern Ireland is home to around 250 life sciences businesses, supporting approximately 18,000 jobs and contributing 1.1 billion GBP to the regional economy. The new hub, hosted by Invest Northern Ireland at its central Belfast offices, is designed to bring regulatory expertise closer to these organisations, helping accelerate innovation, clinical research and the development of new medical technologies.
A key feature of the hub will be periodic in‑person “surgery sessions” where local companies, researchers and clinicians can meet MHRA technical specialists. These sessions will offer guidance on innovation pathways, clinical investigations and regulatory requirements throughout the product development pipeline. The MHRA expects this direct access to support faster development of new therapies and improve the speed at which potentially life‑saving medicines reach patients.
The announcement builds on momentum from the MHRA Board’s meeting in Belfast in November 2025, co‑chaired by MHRA Chair Professor Anthony Harnden and Northern Ireland’s Chief Pharmaceutical Officer, Professor Cathy Harrison.
Professor Harrison welcomed the hub as a reflection of the “strong collaborative relationship” between Northern Ireland agencies and the MHRA. She noted that the initiative will support innovation, improve population health and contribute to economic development.
MHRA Chief Executive Lawrence Tallon described Northern Ireland’s “unique geo‑strategic position,” with access to UK, EU and US markets, as a major advantage. He said the new hub represents an exciting phase for the regulator, enabling it to contribute more directly to the region’s thriving economy and draw on its deep pool of scientific talent.
The Author used AI in preparing this article. Comments upon or questions about this article can be addressed to chris.whitehouse@whitehousecomms.com.
